Late Toxicity of Radiation for Breast Cancer: Overblown or Underappreciated?

This session will focus on late toxicity of radiation for breast cancer, with the theme of whether these risks are overblown or under-appreciated. Along with the introduction and a question and answer session, there are four videos, each approximately 15 minutes:

  • Impact of Radiation on Reconstruction after Mastectomy
  • Risk of Lymphedema after Radiation for Breast Cancer
  • Risk of Cardiac Morbidity and Mortality after Radiation for Breast Cancer
  • Risk of Second Malignancy after Radiation for Breast Cancer

The focus will be on tailored risk assessment for each of these potential toxicities, considerations for including risk of toxicity in management decisions, and toxicity management strategies.

This activity is available from December 12, 2017, through 11:59 p.m. Eastern time on December 11, 2020.

This activity was originally recorded at ASTRO’s 2017 Annual Meeting, September 24-27, 2017 in San Diego, CA.

Target Audience

This program is designed to meet the interest of radiation oncologists, radiation therapists, and radiation dosimetrists.

Learning Objectives

After this session, attendees should be able to:

  • Define the impact of radiation on reconstruction after mastectomy.
  • Identify lymphedema risks and apply strategies for risk reduction.
  • Identify cardiac risks and develop tools for including risk assessment in management decisions.
Course summary
Available credit: 
  • 1.50 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.

  • 1.50 Certificate of Attendance
    This activity was designated for 1.50 AMA PRA Category 1 Credit™.
Course opens: 
12/13/2017
Course expires: 
12/12/2020
Cost:
$105.00
Rating: 
0
  • Jean Wright, MD is employed by Johns Hopkins University and has no financial relationships with a commercial interest.

  • Julia S. Wong, MD is employed by Brigham and Women's Physician Organization and has no financial relationships with a commercial interest.

  • Alphonse Taghian, MD, PhD, FASTRO is employed by Massachusetts General Hospital and receives compensation/remuneration/funding from Impedimed, UpToDate and VisionRT.

  • David Wazer, MD, FASTRO is employed by Tufts Medical Center Physicians Organization and has ownership or investment interests at Advanced Radiation Therapy, Inc , Cancer Care International, Inc., PointSource Technologies, LLC, Rogers Sciences, Inc., and Wolters Kluwer, and holds leadership positions at Brown University and Lifespan Cancer Institute.

  • Sarah Nicole Hamilton, MD is employed by British Columbia Cancer Agency has no financial relationships with a commercial interest. 

The person(s) above served as the developer(s) of this activity. Additionally, the Education and CME/MOC Committees had control over the content of this activity.

 

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

Available Credit

  • 1.50 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.

  • 1.50 Certificate of Attendance
    This activity was designated for 1.50 AMA PRA Category 1 Credit™.

Accreditation Period

Course opens: 
12/13/2017
Course expires: 
12/12/2020

Price

Cost:
$105.00
Please login or register to take this course.

Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.

  • Nonmember: $105
  • Member: $55

Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.

Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.

The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.